SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syncom Formulations (India) completes civil structure at Pithampur unit

16 Sep 2022 Evaluate

Syncom Formulations (India) has completed civil structure at company's existing plant at Pithampur in Madhya Pradesh and machine installations are under progress. However, due to certain delays in machine supply, the project is delayed and the company is hoping to start production in the fourth quarter of the financial year.

Syncom Formulations (India) is a renowned name in the Indian Pharmaceutical Industry representing synergistic combination of commitment and consistency.

Syncom Formulations Share Price

14.18 0.17 (1.21%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: